Patent details
EP3592389 Title: METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT
Basic Information
- Publication number:
- EP3592389
- PCT Application Number:
- US2018021897
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP187149067
- PCT Publication Number:
- WO2018169811
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT
- French Title of Invention:
- PROCÉDÉS ET COMPOSITIONS ASSOCIÉS À UN TRAITEMENT COMBINÉ AVEC ANTI-INFLAMMATOIRES ET NANOVECTEURS SYNTHÉTIQUES COMPRENANT UN IMMUNOSUPPRESSEUR
- German Title of Invention:
- VERFAHREN UND ZUSAMMENSETZUNGEN IN ZUSAMMENHANG MIT EINER KOMBINIERTEN BEHANDLUNG MIT ENTZÜNDUNGSHEMMENDEN MITTELN UND SYNTHETISCHEN NANOTRÄGERN MIT EINEM IMMUNSUPPRESSIVUM
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 29/05/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 06/06/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 07/05/2025
- Unitary Effect Registration Date:
- 06/06/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 11/03/2018
- Grant date:
- 07/05/2025
- EP Publication Date:
- 15/01/2020
- PCT Publication Date:
- 20/09/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/05/2025
- EP B1 Publication Date:
- 07/05/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 11/03/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 30/04/2025
- Name:
- Cartesian Therapeutics, Inc.
- Address:
- 704 Quince Orchard Road Suite 210A, Gaithersburg, MD 20878, United States (US)
Inventor
- Name:
- JOHNSTON, Lloyd
- Address:
- United States (US)
Priority
- Priority Number:
- 201762470250 P
- Priority Date:
- 11/03/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/436; A61K 45/00; A61K 38/43; A61P 29/00; A61K 45/06;
Publication
European Patent Bulletin
1
- Issue number:
- 202519
- Publication date:
- 07/05/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202527
- Publication date:
- 02/07/2025
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202528
- Publication date:
- 09/07/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|